These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3019378)

  • 21. Studies on leucocyte-drug interaction with benoxaprofen.
    Meacock SC; Civil GW; Dawson W; Kitchen EA
    Eur J Rheumatol Inflamm; 1982; 5(2):51-60. PubMed ID: 7084283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood platelets decrease concentration of reactive oxygen species produced by polymorphonuclear leukocytes.
    Jancinova V; Drabikova K; Petrikova M; Nosal R
    Bratisl Lek Listy; 2004; 105(7-8):250-5. PubMed ID: 15543845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The amplified chemiluminescence test to characterize antirheumatic drugs as oxygen radical scavengers.
    Müller-Peddinghaus R; Wurl M
    Biochem Pharmacol; 1987 Apr; 36(7):1125-32. PubMed ID: 3032204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients.
    Hübel E; Kiefer T; Weber J; Mettang T; Kuhlmann U
    Kidney Int; 1991 Nov; 40(5):927-33. PubMed ID: 1662316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregated C-reactive protein binds to human polymorphonuclear leukocytes and potentiates Fc receptor-mediated chemiluminescence.
    Zeller JM; Landay AL; Lint TF; Gewurz H
    J Lab Clin Med; 1986 Dec; 108(6):567-76. PubMed ID: 2946790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of clofazimine analogues and tumor necrosis factor-alpha individually and in combination on human polymorphonuclear leukocyte functions in vitro.
    Krajewska MM; Anderson R; O'Sullivan JF
    Int J Immunopharmacol; 1993 Feb; 15(2):99-111. PubMed ID: 8385654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease.
    Fernandez-Boyanapalli RF; Frasch SC; Thomas SM; Malcolm KC; Nicks M; Harbeck RJ; Jakubzick CV; Nemenoff R; Henson PM; Holland SM; Bratton DL
    J Allergy Clin Immunol; 2015 Feb; 135(2):517-527.e12. PubMed ID: 25498313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective immobilization of human mononuclear phagocytes by benoxaprofen.
    Goetzl EJ; Valone FH
    Arthritis Rheum; 1982 Dec; 25(12):1486-9. PubMed ID: 7150381
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of benoxaprofen on mononuclear and polymorphonuclear leucocyte motility.
    Naudé SP; Anderson R; Theron A; Eftychis EA
    S Afr Med J; 1982 Oct; 62(19):680. PubMed ID: 7135123
    [No Abstract]   [Full Text] [Related]  

  • 30. Benoxaprofen photosensitization of cell membrane disruption.
    Kochevar IE; Hoover KW; Gawienowski M
    J Invest Dermatol; 1984 Mar; 82(3):214-8. PubMed ID: 6699424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of induction of suppressor activity in human mononuclear leukocytes by ascorbate and cysteine in vitro.
    Eftychis H; Anderson R
    Int J Vitam Nutr Res; 1983; 53(4):398-401. PubMed ID: 6230331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein selectively enhances the intracellular generation of reactive oxygen products by IgG-stimulated monocytes and neutrophils.
    Zeller JM; Sullivan BL
    J Leukoc Biol; 1992 Oct; 52(4):449-55. PubMed ID: 1328445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemiluminescence in microamounts of whole blood for investigation of the human phagocyte oxidative metabolism function.
    Descamps-Latscha B; Nguyen AT; Golub RM; Feuillet-Fieux MN
    Ann Immunol (Paris); 1982; 133C(3):349-64. PubMed ID: 6756282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.
    Bass DA; Parce JW; Dechatelet LR; Szejda P; Seeds MC; Thomas M
    J Immunol; 1983 Apr; 130(4):1910-7. PubMed ID: 6833755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen metabolism of human colostral macrophages: comparison with monocytes and polymorphonuclear leukocytes.
    Tsuda H; Takeshige K; Shibata Y; Minakami S
    J Biochem; 1984 May; 95(5):1237-45. PubMed ID: 6086600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Priming of phagocytes by cytokines and water-soluble products of lipid peroxidation.
    Koval'chuk LV; Klebanov GI; Ribarov SR; Kreinina MV; Aptsiauri NE; Gankowskaya LW; Karaseva MV; Shuikina EE; Vladimirov YuA
    Biomed Sci; 1991; 2(3):221-31. PubMed ID: 1751754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.
    Harvath L; Amirault HJ; Andersen BR
    J Clin Invest; 1978 May; 61(5):1145-54. PubMed ID: 207727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene biosynthesis by polymorphonuclear leukocytes from two patients with chronic granulomatous disease.
    Feinmark SJ; Udén AM; Palmblad J; Malmsten C
    J Clin Invest; 1983 Nov; 72(5):1839-43. PubMed ID: 6313767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolism.
    Roch-Arveiller M; Revelant V; Pham Huy D; Maman L; Fontagne J; Sorenson JR; Giroud JP
    Agents Actions; 1990 Aug; 31(1-2):65-71. PubMed ID: 2178320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E protects mononuclear leucocyte DNA against damage mediated by phagocyte-derived oxidants.
    van Staden AM; van Rensburg CE; Anderson R
    Mutat Res; 1993 Aug; 288(2):257-62. PubMed ID: 7688085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.